| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| R&D Expense | $196K | — |
| SG&A Expense | $282K | -6.8% |
| Operating Income | -$1.9M | +7.1% |
| Interest Expense | $1.2M | — |
| Net Income | -$3.1M | +56.1% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Current Assets | $664K | +904.0% |
| Total Assets | $713K | +326.6% |
| Current Liabilities | $9.3M | +38.1% |
| Total Liabilities | $9.3M | +37.4% |
| Stockholders' Equity | -$5.8M | -51.7% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.4M | -21.8% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | -$8K | +95.9% |
| Financing Cash Flow | $2.0M | +448.6% |
| Free Cash Flow | -$1.4M | -21.5% |